Laboratory Corporation of Ameri Price Today
Laboratory Corporation of Ameri
LH
Healthcare
$19.07B
💰
Market Cap
19.3
💸
Price to Earnings
$11.1
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
12 |
Strong Buy |
8 |
Hold |
5 |
Sell |
0 |
Strong Sell |
0 |
LH Price Forecast Target
215.2 👉 290.0 +35%
LH EPS Forecast
11.1 👉 15.0 +35%
Financials
Profit Margin
6 %
Revenue Growth
-17.9 %
Dividend
$ 2.88
Held Percent
0.3% - Insiders
93.3% - Institutions
6.4% - Public
Major Fund Holders
-
💰 Blackrock Inc. $2.7B
-
💰 Vanguard Group Inc $2.4B
-
💰 State Street Corporation $902.6M
-
💰 Wellington Management Group, LLP $619.7M
-
💰 Geode Capital Management, LLC $422.8M
Stock Ideas
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…
Ken Fisher Portfolio
Ken Fisher is a prominent American investment analyst, author, and the founder of Fisher Investments, a global investment firm managing billions of dollars in assets for individual and institutional clients. As a highly successful investor and fina…
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…📮FAQ
Some Frequently Asked Questions.
The Laboratory Corporation of Ameri industry is Diagnostics & Research
The Laboratory Corporation of Ameri sector is Healthcare
The Laboratory Corporation of Ameri forecasted predicted Price to Earnings PE ratio is 14.4
The Laboratory Corporation of Ameri Price to Earnings PE ratio is 19.3
The Market Capitalization of Laboratory Corporation of Ameri is $19.07B
There are total of 88393098 float shares with 93.3% held by Institutions and 0.3% held by insiders
The MLaboratory Corporation of Ameri forecasted Earnings per Share EPS is $15.0
The Laboratory Corporation of Ameri Earnings per Share EPS is 11.1
The Laboratory Corporation of Ameri company has $4385100000 gross profits with 6 profit margins
The Laboratory Corporation of Ameri Earnings Growth is -0.452% with -0.473% quarterly earnings growth
The Laboratory Corporation of Ameri Revenue is $14880799744 with -0.179 revenue growth
The price target for Laboratory Corporation of Ameri stock is $290.0 for the high target and $215.0 for the low target
The consensus analyst recommendations for Laboratory Corporation of Ameri is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Laboratory Corporation of Ameri is Buy, with the following breakdown:
- Buy: 12
- Strong Buy: 8
- Hold: 5
- Sell: 0
- Strong Sell: 0
The Beta of Laboratory Corporation of Ameri is 1.1
The dividend of Laboratory Corporation of Ameri is $2.88
The dividend yield of Laboratory Corporation of Ameri is 0.0135%
The biggest institutional and mutual fund holders of Laboratory Corporation of Ameri stock are
- Blackrock Inc.
- Vanguard Group Inc
- State Street Corporation
- Wellington Management Group, LLP
The Laboratory Corporation of Ameri ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0